DOCSLIB.ORG

Meyer2012.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meyer2012.Pdf This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: • This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. • A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. • This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. • The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. • When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Characterisation of the Direct Antiproliferative Effects of a Gonadotrophin-releasing Hormone Analogue Colette Meyer A thesis submitted in fulfilment of the requirements of the degree of Doctor of Philosophy The University of Edinburgh 2012 1 Abstract Gonadotrophin-releasing hormone (GnRH) can inhibit proliferation of multiple reproductive tissue cancer cell lines through direct interaction with GnRH receptors (GnRHR) on tumour cells. GnRH analogues may therefore have a role in treating some cancers. The signalling pathways associated with these inhibitory effects are poorly defined, and characterising them may help to understand therapeutic sensitivity. To elucidate these pathways, transcriptomic and proteomic approaches were used to compare the effects of the GnRH agonist Triptorelin in responsive GnRHR-transfected HEK293 cells (SCL60) and unresponsive (HEK293) cells both in vitro for up to 24h and in vivo for up to 7 days. Gene expression profiling demonstrated that SCL60 gene expression was temporally regulated with Triptorelin treatment, with expression of some genes increased at one time point but decreased at another. Early and mid-phase gene expression changes comprised mainly transcription factors and late changes included the hormonal signalling component CGA . Pathway analysis implicated mitogen-activated protein kinase and cell cycle pathways, supporting the detection of G 2/M arrest. Signalling effects within SCL60 xenografts, 4 and 7 days following Triptorelin treatment, were investigated using a phosphoproteomic antibody array. Changes included cell cycle and apoptosis regulators, as well as cell surface receptors and NF κB signalling pathway members. Reverse-phase protein arrays and western blotting also showed that pAkt was decreased and pNFκB-p65 was increased after Triptorelin treatment in vitro . An NF κB inhibitor enhanced the anti-proliferative effect of Triptorelin in SCL60 cells in vitro, suggesting that NF κB acts as a survival factor in the response to GnRHR stimulation. A range of GnRHR expression was observed in breast cancer tumours by immunohistochemistry, and on average GnRHR expression was significantly higher in the Triple Negative Phenotype (TNP) subgroup and in grade 3 tumours. A GnRHR-transfected breast cancer cell line, MCF7-h14, was developed. Despite this expressing a similar level of GnRHR to responsive SCL60 cells, MCF7-h14 cells were not inhibited by GnRHR activation, indicating that a high level of GnRHR is insufficient for the antiproliferative effects of Triptorelin. 2 Declaration The work in this thesis is solely my own work unless otherwise indicated, where credit to the contributor is given. No part of the work has been submitted for any other degree. Colette Meyer Acknowledgements I thank my supervisors Simon Langdon, Andy Sims, Kevin Morgan, Dana Faratian and David Harrison. I thank all my colleagues in the Breakthrough Research Unit, Edinburgh who have assisted me with experiments. I would also like to thank Kevin Morgan and Nicola Miller of the MRC Human Reproductive Sciences Unit, Queen’s Medical Research Institute, Edinburgh for their support and expertise. The SCL60 and SCL215 cell lines and their parental HEK293 cells were provided by Kevin Morgan. Mouse SCL60 and HEK293 xenograft experiments were performed by Morwenna Muir (University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh) as a scientific service. Tissue from the SCL60 xenografts was used in immunohistochemical assays. Inhwa Um (Research Assistant, Breakthrough Research Unit, Edinburgh) constructed tissue microarrays from the SCL60 xenografts. Immunohistochemical staining for all markers except GnRHR was performed by myself, with the supervision of Simon Langdon, who also scored some of the slides. I prepared samples for flow cytometry analysis, which were processed on the flow cytometer by Elisabeth Freyer (Flow Cytometry Service, MRC Human Genetics Unit, Western General Hospital, Edinburgh) as a scientific service. 3 I designed the gene expression microarray study with the supervision of Simon Langdon and Andy Sims. I performed the cell treatments, RNA extractions, purifications and labelling. Alexey Larionov (Research Fellow, Breakthrough Research Unit, Edinburgh) provided advice on the labelling procedure. Charlene Kay (Research Assistant, Breakthrough Research Unit, Edinburgh), Annelein Zweemer (Student, Breakthrough Research Unit, Edinburgh) and Huizhong Hu (Student, Breakthrough Research Unit, Edinburgh) assisted with the procedure for biotin- labelling RNA under my direction. The microarrays were processed by the Wellcome Trust Clinical Research Facility, Western General Hospital, Edinburgh as a scientific service. I filtered and normalised the resultant data, and performed quality control checks. I performed the analyses to detect differential gene expression. SCL60 xenografts antibody arrays were performed by Eurogentec as a scientific service. They provided data for phosphorylated protein normalised to non- phosphorylated protein, which I analysed for significant differences between treatment groups. Peter Mullen (Research Assistant, Breakthrough Research Unit, Edinburgh) provided advice on processing the reverse-phase protein arrays. I designed the experiments, collected the protein, standardised the protein concentration across samples, performed the arrays and analysed the data. I performed all western blots in chapter 3.3. Ilgin Cagnan, a student working under my supervision, measured GnRHR expression by quantitative immunofluorescence. The tissue microarrays used were provided by Dana Faratian, and are detailed in the publication “Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases, Aitken et al , Ann Oncol, 2009” [1]. The resulting data was analysed by myself. Andy Sims and I both analysed the mRNA level of GnRHR in published datasets of breast cancers. Andy Sims provided Figure 61. 4 Kevin Morgan performed the stable transfection of breast cancer cell lines, and experiments in chapter 3.6 of this thesis were done collaboratively between Kevin Morgan and myself, with the exception of Figure 78 and Figure 84, which were provided by Kevin Morgan. Funding for this research project was provided by Breakthrough Breast Cancer. Part of this thesis is published in the BMC cancer paper: “GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines, Morgan K, Meyer C, Miller N, Sims AH, Cagnan I, Faratian D, Harrison DJ, Millar RP, Langdon SP, 2011”. Kevin Morgan prepared the manuscript. Kevin Morgan, myself and Nicola Miller performed ligand binding assays, SRB assays and western blots. Ilgin Cagnan measured GnRHR primary breast tissue microarrays by immunofluorescence. I analysed the immunofluorescence data. Dana Faratian and provided tissue and clinical data for immunofluorescence analysis. Andy Sims, Dana Faratian, David Harrison, Robert Millar and Simon Langdon contributed intellectually, in supervision, and in manuscript preparation. 5 List of Contents Abstract ........................................................................................................................ 2 Declaration ................................................................................................................... 3 Acknowledgements...................................................................................................... 3 List of Contents............................................................................................................ 6 List of Figures ............................................................................................................ 11 List of Tables.............................................................................................................. 15 List of Abbreviations.................................................................................................. 16 1 Introduction............................................................................................................. 20 1.1 Breast cancer .................................................................................................... 20 1.1.1 The Hallmarks of Cancer .......................................................................... 20 1.1.2 Breast Biology........................................................................................... 22 1.1.3 Breast Cancer Background........................................................................ 23 1.1.3.1 Epidemiology....................................................................................
Load more

Recommended publications
  • C8cc08685k1.Pdf
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2018 Supporting Information Minimalist Linkers Suitable for Irreversible Inhibitors in Simultaneous Proteome Profiling, Live-Cell Imaging and Drug Screening Cuiping Guo,Yu Chang, Xin Wang, Chengqian Zhang, Piliang Hao*, Ke Ding and Zhengqiu Li* School of Pharmacy, Jinan University, Guangzhou, China 510632 *Corresponding author ([email protected]) 1. General Information All chemicals were purchased from commercial vendors and used without further purification, unless indicated otherwise. All reactions requiring anhydrous conditions were carried out under argon or nitrogen atmosphere using oven-dried glassware. AR-grade solvents were used for all reactions. Reaction progress was monitored by TLC on pre-coated silica plates (Merck 60 F254 nm, 0.25 µm) and spots were visualized by UV, iodine or other suitable stains. Flash column chromatography was carried out using silica gel (Qingdao Ocean). All NMR spectra (1H-NMR, 13C-NMR) were recorded on Bruker 300 MHz/400 MHz NMR spectrometers. Chemical shifts were reported in parts per million (ppm) referenced with respect to appropriate internal standards or residual solvent peaks (CDCl3 = 7.26 ppm, DMSO-d6 = 2.50 ppm). The following abbreviations were used in reporting spectra, br s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublets). Mass spectra were obtained on Agilent LC-ESI-MS system. All analytical HPLC were carried out on Agilent system. Water with 0.1% TFA and acetonitrile with 0.1% TFA were used as eluents and the flow rate was 0.5 mL/min.
    [Show full text]
  • Divergence of Human and Mouse Brain Transcriptome Highlights Alzheimer Disease Pathways
    Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways Jeremy A. Millera,b, Steve Horvathc,d, and Daniel H. Geschwindb,c,1 aInterdepartmental Program for Neuroscience, Departments of cHuman Genetics and dBiostatistics, and bProgram in Neurogenetics and Neurobehavioral Genetics, Department of Neurology and Semel Institute, University of California, Los Angeles, CA 90095-1769 Edited by Joseph S. Takahashi, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, and approved June 1, 2010 (received for review December 10, 2009) Because mouse models play a crucial role in biomedical research works by merging data from many microarray studies, and then related to the human nervous system, understanding the similari- applying weighted gene coexpression network analysis (WGCNA) ties and differences between mouse and human brain is of (4–7). WGCNA elucidates the higher-order relationships between fundamental importance. Studies comparing transcription in hu- genes based on their coexpression relationships, delineating modules man and mouse have come to varied conclusions, in part because of of biologically related genes and permitting a robust view of their relatively small sample sizes or underpowered methodologies. transcriptome organization (3, 5, 8, 9). Within groups of highly coexpressed genes (“modules”) that comprise the core functional To better characterize gene expression differences between mouse fi and human, we took a systems-biology approach by using weighted units of the transcriptional network, WGCNA also identi es gene coexpression network analysis on more than 1,000 micro- the most highly connected, or most central genes within each module, referred to as “hubs.” We find that both gene expression arrays from brain.
    [Show full text]
  • Associated 16P11.2 Deletion in Drosophila Melanogaster
    ARTICLE DOI: 10.1038/s41467-018-04882-6 OPEN Pervasive genetic interactions modulate neurodevelopmental defects of the autism- associated 16p11.2 deletion in Drosophila melanogaster Janani Iyer1, Mayanglambam Dhruba Singh1, Matthew Jensen1,2, Payal Patel 1, Lucilla Pizzo1, Emily Huber1, Haley Koerselman3, Alexis T. Weiner 1, Paola Lepanto4, Komal Vadodaria1, Alexis Kubina1, Qingyu Wang 1,2, Abigail Talbert1, Sneha Yennawar1, Jose Badano 4, J. Robert Manak3,5, Melissa M. Rolls1, Arjun Krishnan6,7 & 1234567890():,; Santhosh Girirajan 1,2,8 As opposed to syndromic CNVs caused by single genes, extensive phenotypic heterogeneity in variably-expressive CNVs complicates disease gene discovery and functional evaluation. Here, we propose a complex interaction model for pathogenicity of the autism-associated 16p11.2 deletion, where CNV genes interact with each other in conserved pathways to modulate expression of the phenotype. Using multiple quantitative methods in Drosophila RNAi lines, we identify a range of neurodevelopmental phenotypes for knockdown of indi- vidual 16p11.2 homologs in different tissues. We test 565 pairwise knockdowns in the developing eye, and identify 24 interactions between pairs of 16p11.2 homologs and 46 interactions between 16p11.2 homologs and neurodevelopmental genes that suppress or enhance cell proliferation phenotypes compared to one-hit knockdowns. These interac- tions within cell proliferation pathways are also enriched in a human brain-specific network, providing translational relevance in humans. Our study indicates a role for pervasive genetic interactions within CNVs towards cellular and developmental phenotypes. 1 Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA. 2 Bioinformatics and Genomics Program, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.
    [Show full text]
  • The Human Genome Project
    TO KNOW OURSELVES ❖ THE U.S. DEPARTMENT OF ENERGY AND THE HUMAN GENOME PROJECT JULY 1996 TO KNOW OURSELVES ❖ THE U.S. DEPARTMENT OF ENERGY AND THE HUMAN GENOME PROJECT JULY 1996 Contents FOREWORD . 2 THE GENOME PROJECT—WHY THE DOE? . 4 A bold but logical step INTRODUCING THE HUMAN GENOME . 6 The recipe for life Some definitions . 6 A plan of action . 8 EXPLORING THE GENOMIC LANDSCAPE . 10 Mapping the terrain Two giant steps: Chromosomes 16 and 19 . 12 Getting down to details: Sequencing the genome . 16 Shotguns and transposons . 20 How good is good enough? . 26 Sidebar: Tools of the Trade . 17 Sidebar: The Mighty Mouse . 24 BEYOND BIOLOGY . 27 Instrumentation and informatics Smaller is better—And other developments . 27 Dealing with the data . 30 ETHICAL, LEGAL, AND SOCIAL IMPLICATIONS . 32 An essential dimension of genome research Foreword T THE END OF THE ROAD in Little has been rapid, and it is now generally agreed Cottonwood Canyon, near Salt that this international project will produce Lake City, Alta is a place of the complete sequence of the human genome near-mythic renown among by the year 2005. A skiers. In time it may well And what is more important, the value assume similar status among molecular of the project also appears beyond doubt. geneticists. In December 1984, a conference Genome research is revolutionizing biology there, co-sponsored by the U.S. Department and biotechnology, and providing a vital of Energy, pondered a single question: Does thrust to the increasingly broad scope of the modern DNA research offer a way of detect- biological sciences.
    [Show full text]
  • Evolutionary Analysis of Viral Sequences in Eukaryotic Genomes
    Evolutionary analysis of viral sequences in eukaryotic genomes Sean Schneider A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2014 Reading Committee: James H. Thomas, Chair Willie Swanson Phil Green Program Authorized to Offer Degree: Genome Sciences ©Copyright 2014 Sean Schneider University of Washington Abstract Evolutionary analysis of viral sequences in eukaryotic genomes Sean Schneider Chair of the supervisory committee: Professor James H. Thomas Genome Sciences The focus of this work is several evolutionary analyses of endogenous viral sequences in eukaryotic genomes. Endogenous viral sequences can provide key insights into the past forms and evolutionary history of viruses, as well as the responses of host organisms they infect. In this work I have examined viral sequences in a diverse assortment of eukaryotic hosts in order to study coevolution between hosts and the organisms that infect them. This research consisted of two major lines of investigation. In the first portion of this work, I outline the hypothesis that the C2H2 zinc finger gene family in vertebrates has evolved by birth-death evolution in response to sporadic retroviral infection. The hypothesis suggests an evolutionary model in which newly duplicated zinc finger genes are retained by selection in response to retroviral infection. This hypothesis is supported by a strong association (R2=0.67) between the number of endogenous retroviruses and the number of zinc fingers in diverse vertebrate genomes. Based on this and other evidence, the zinc finger gene family appears to act as a “genomic immune system” against retroviral infections. The other major line of investigation in this work examines endogenous virus sequences utilized by parasitic wasps to disable hosts that they infect.
    [Show full text]
  • Changes in Prostate Gene Expression in Men Undergoing an Intensive Nutrition and Lifestyle Intervention
    Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention Dean Ornish*†‡, Mark Jesus M. Magbanua§, Gerdi Weidner*, Vivian Weinberg¶, Colleen Kemp*, Christopher Green§, Michael D. Mattie§, Ruth Marlin*, Jeff Simkoʈ, Katsuto Shinohara§, Christopher M. Haqq§ and Peter R. Carroll§ §Department of Urology, The Helen Diller Family Comprehensive Cancer Center, and ʈDepartment of Pathology, University of California, 2340 Sutter Street, San Francisco, CA 94115; *Preventive Medicine Research Institute, 900 Bridgeway, Sausalito, CA 94965; †Department of Medicine, School of Medicine, University of California, 505 Parnassus Avenue, San Francisco, CA 94143; and ¶Biostatistics Core, The Helen Diller Family Comprehensive Cancer Center, University of California, 513 Parnassus Avenue, Box 0127, San Francisco, CA 94143 Communicated by J. Craig Venter, The J. Craig Venter Institute, Rockville, MD, April 2, 2008 (received for review February 13, 2008) Epidemiological and prospective studies indicate that comprehensive indolent low-risk prostate cancers, defined by strict clinical and lifestyle changes may modify the progression of prostate cancer. pathologic criteria designed to minimize the risk for metastatic However, the molecular mechanisms by which improvements in diet disease as a result of study participation (9). The 30 men who and lifestyle might affect the prostate microenvironment are poorly enrolled did not undergo surgery or radiation therapy to treat their understood. We conducted a pilot study to examine changes in low-risk tumors; rather, they underwent comprehensive lifestyle prostate gene expression in a unique population of men with low-risk changes (low-fat, whole-foods, plant-based nutrition; stress man- prostate cancer who declined immediate surgery, hormonal therapy, agement techniques; moderate exercise; and participation in a or radiation and participated in an intensive nutrition and lifestyle psychosocial group support).
    [Show full text]
  • The Changing Chromatome As a Driver of Disease: a Panoramic View from Different Methodologies
    The changing chromatome as a driver of disease: A panoramic view from different methodologies Isabel Espejo1, Luciano Di Croce,1,2,3 and Sergi Aranda1 1. Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain 2. Universitat Pompeu Fabra (UPF), Barcelona, Spain 3. ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain *Corresponding authors: Luciano Di Croce ([email protected]) Sergi Aranda ([email protected]) 1 GRAPHICAL ABSTRACT Chromatin-bound proteins regulate gene expression, replicate and repair DNA, and transmit epigenetic information. Several human diseases are highly influenced by alterations in the chromatin- bound proteome. Thus, biochemical approaches for the systematic characterization of the chromatome could contribute to identifying new regulators of cellular functionality, including those that are relevant to human disorders. 2 SUMMARY Chromatin-bound proteins underlie several fundamental cellular functions, such as control of gene expression and the faithful transmission of genetic and epigenetic information. Components of the chromatin proteome (the “chromatome”) are essential in human life, and mutations in chromatin-bound proteins are frequently drivers of human diseases, such as cancer. Proteomic characterization of chromatin and de novo identification of chromatin interactors could thus reveal important and perhaps unexpected players implicated in human physiology and disease. Recently, intensive research efforts have focused on developing strategies to characterize the chromatome composition. In this review, we provide an overview of the dynamic composition of the chromatome, highlight the importance of its alterations as a driving force in human disease (and particularly in cancer), and discuss the different approaches to systematically characterize the chromatin-bound proteome in a global manner.
    [Show full text]
  • UNIVERSITY of CALIFORNIA Los Angeles Identification of a Multisubunit E3 Ubiquitin Ligase Required for Heterotrimeric G-Protein
    UNIVERSITY OF CALIFORNIA Los Angeles Identification of a multisubunit E3 ubiquitin ligase required for heterotrimeric G-protein beta-subunit ubiquitination and cAMP signaling A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Molecular Biology by Brian Daniel Young 2018 © Copyright by Brian Daniel Young 2018 ABSTRACT OF THE DISSERTATION Identification of a multisubunit E3 ubiquitin ligase required for heterotrimeric G-protein beta-subunit ubiquitination and cAMP signaling by Brian Daniel Young Doctor of Philosophy in Molecular Biology University of California, Los Angeles, 2018 Professor James Akira Wohlschlegel, Chair GPCRs are stimulated by extracellular ligands and initiate a range of intracellular signaling events through heterotrimeric G-proteins. Upon activation, G-protein α- subunits (Gα) and the stable βγ-subunit dimer (Gβγ) bind and alter the activity of diverse effectors. These signaling events are fundamental and subject to multiple layers of regulation. In this study, we used an unbiased proteomic mass spectrometry approach to uncover novel regulators of Gβγ. We identified a subfamily of potassium channel tetramerization domain (KCTD) proteins that specifically bind Gβγ. Several KCTD proteins are substrate adaptor proteins for CUL3–RING E3 ubiquitin ligases. Our studies revealed that a KCTD2-KCTD5 hetero-oligomer associates with CUL3 through KCTD5 subunits and recruits Gβγ through both subunits. Using in vitro ubiquitination reactions, we demonstrated that these KCTD proteins promote monoubiquitination of lysine-23 within Gβ1/2. This ubiquitin modification of Gβ1/2 is also observed in human ii cells and is dependent on these substrate adaptor proteins. Because these KCTD proteins bind Gβγ in response to G-protein activation, we investigated their role in GPCR signaling.
    [Show full text]
  • Cross-Talk Between PRMT1-Mediated Methylation and Ubiquitylation on RBM15 Controls RNA Splicing
    1 Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing 2 Li Zhang1*, Ngoc-Tung Tran1*, Hairui Su1*, Rui Wang2, Yuheng Lu11, Haiping Tang4, Sayura Aoyagi10, 3 Ailan Guo10, Alireza Khodadadi-Jamayran1, Dewang Zhou1, Kun Qian5, Todd Hricik3, Jocelyn Côté6, 4 Xiaosi Han8, Wenping Zhou7, Suparna Laha9, Omar Abdel-Wahab3, Ross L. Levine3, Glen Raffel9, 5 Yanyan Liu7, Dongquan Chen12, Haitao Li4, Tim Townes1, Hengbin Wang1, Haiteng Deng4, Y. George 6 Zheng5, Christina Leslie11, Minkui Luo2, and Xinyang Zhao1 7 8 1. Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute, The University of 9 Alabama at Birmingham, Birmingham, AL 35294, USA. 10 2. Program of Molecular Pharmacology, Sloan Kettering Institute, New York, NY 10021, USA. 11 3. HOPP, Sloan Kettering Institute, New York, NY 10021, USA. 12 4. School of Life Sciences, Tsinghua University, Beijing, 100084 China. 13 5. Department of Pharmaceutical & Biomedical Sciences, The University of Georgia, Athens, GA 14 30602, USA 15 6. Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, 16 ON K1H 8M5, Canada. 17 7. Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University & Henan 18 Cancer Hospital, Zhengzhou 450008, China 19 8. Department of Neurology, Comprehensive Cancer Center, The University of Alabama at 20 Birmingham, Birmingham, AL 35294, USA. 21 9. Division of Hematology and Oncology, University of Massachusetts Medical School, 364 22 Plantation St, Worcester, MA 01605, USA. 23 10. Cell Signaling Inc. 3 Trask lane, Danvers, MA 01923, USA. 24 11. Computational Biology Program, Sloan Kettering Institute, New York, NY 10021, USA.
    [Show full text]
  • Divergence of Human and Mouse Brain Transcriptome Highlights Alzheimer Disease Pathways
    Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways Jeremy A. Millera,b, Steve Horvathc,d, and Daniel H. Geschwindb,c,1 aInterdepartmental Program for Neuroscience, Departments of cHuman Genetics and dBiostatistics, and bProgram in Neurogenetics and Neurobehavioral Genetics, Department of Neurology and Semel Institute, University of California, Los Angeles, CA 90095-1769 Edited by Joseph S. Takahashi, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, and approved June 1, 2010 (received for review December 10, 2009) Because mouse models play a crucial role in biomedical research works by merging data from many microarray studies, and then related to the human nervous system, understanding the similari- applying weighted gene coexpression network analysis (WGCNA) ties and differences between mouse and human brain is of (4–7). WGCNA elucidates the higher-order relationships between fundamental importance. Studies comparing transcription in hu- genes based on their coexpression relationships, delineating modules man and mouse have come to varied conclusions, in part because of of biologically related genes and permitting a robust view of their relatively small sample sizes or underpowered methodologies. transcriptome organization (3, 5, 8, 9). Within groups of highly coexpressed genes (“modules”) that comprise the core functional To better characterize gene expression differences between mouse fi and human, we took a systems-biology approach by using weighted units of the transcriptional network, WGCNA also identi es gene coexpression network analysis on more than 1,000 micro- the most highly connected, or most central genes within each module, referred to as “hubs.” We find that both gene expression arrays from brain.
    [Show full text]
  • Ep 2327796 A1
    (19) & (11) EP 2 327 796 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 01.06.2011 Bulletin 2011/22 C12Q 1/68 (2006.01) (21) Application number: 10184813.3 (22) Date of filing: 09.06.2004 (84) Designated Contracting States: • Spira, Avrum AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Newton, Massachusetts 02465 (US) HU IE IT LI LU MC NL PL PT RO SE SI SK TR (74) Representative: Brown, David Leslie (30) Priority: 10.06.2003 US 477218 P Haseltine Lake LLP Redcliff Quay (62) Document number(s) of the earlier application(s) in 120 Redcliff Street accordance with Art. 76 EPC: Bristol 04776438.6 / 1 633 892 BS1 6HU (GB) (71) Applicant: THE TRUSTEES OF BOSTON Remarks: UNIVERSITY •This application was filed on 30-09-2010 as a Boston, MA 02218 (US) divisional application to the application mentioned under INID code 62. (72) Inventors: •Claims filed after the date of filing of the application/ • Brody, Jerome S. after the date of receipt of the divisional application Newton, Massachusetts 02458 (US) (Rule 68(4) EPC). (54) Detection methods for disorders of the lung (57) The present invention is directed to prognostic vides a minimally invasive sample procurement method and diagnostic methods to assess lung disease risk in combination with the gene expression-based tools for caused by airway pollutants by analyzing expression of the diagnosis and prognosis of diseases of the lung, par- one or more genes belonging to the airway transcriptome ticularly diagnosis and prognosis of lung cancer provided herein.
    [Show full text]
  • Large-Scale Analysis of Lysine Sumoylation by SUMO Remnant Immunoaffinity Profiling
    ARTICLE Received 23 Apr 2014 | Accepted 29 Sep 2014 | Published 13 Nov 2014 DOI: 10.1038/ncomms6409 Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling Fre´de´ric Lamoliatte1,2,*, Danielle Caron1,*, Chantal Durette1, Louiza Mahrouche1,3, Mohamed Ali Maroui4, Olivier Caron-Lizotte1, Eric Bonneil1, Mounira K. Chelbi-Alix4 & Pierre Thibault1,2,3 Small ubiquitin-related modifiers (SUMO) are evolutionarily conserved ubiquitin-like proteins that regulate several cellular processes including cell cycle progression, intracellular trafficking, protein degradation and apoptosis. Despite the importance of protein SUMOylation in different biological pathways, the global identification of acceptor sites in complex cell extracts remains a challenge. Here we generate a monoclonal antibody that enriches for peptides containing SUMO remnant chains following tryptic digestion. We identify 954 SUMO3-modified lysine residues on 538 proteins and profile by quantitative proteomics the dynamic changes of protein SUMOylation following proteasome inhibition. More than 86% of these SUMOylation sites have not been reported previously, including 5 sites on the tumour suppressor parafibromin (CDC73). The modification of CDC73 at K136 affects its nuclear retention within PML nuclear bodies on proteasome inhibition. In contrast, a CDC73 K136R mutant translocates to the cytoplasm under the same conditions, further demonstrating the effectiveness of our method to characterize the dynamics of lysine SUMOylation. 1 Institute for Research in Immunology and Cancer, Universite´ de Montre´al, PO Box 6128, Station Centre-ville, Montre´al, Que´bec, Canada H3C 3J7. 2 Department of Chemistry, Universite´ de Montre´al, PO Box 6128, Station Centre-ville, Montre´al, Que´bec, Canada H3C 3J7. 3 Department of Biochemistry, Universite´ de Montre´al, PO Box 6128, Station Centre-ville, Montre´al, Que´bec, Canada H3C 3J7.
    [Show full text]